Impact of age on acute toxicity induced by bio- or chemo-radiotherapy in patients with head and neck cancer

Oral Oncol. 2012 Oct;48(10):1051-1057. doi: 10.1016/j.oraloncology.2012.05.001. Epub 2012 Jun 2.

Abstract

Introduction: The purpose of this study is to retrospectively analyze acute toxicity encountered in young and old patients treated with chemo-radiation or bio-radiation at the S. Croce General Hospital between 1997 and 2008, in daily clinical practice.

Material and methods: Three hundred and seventeen patients were allocated into two groups according to age (cut-off 65 years). The two groups were compared in terms of treatment related toxicities, treatment activity and efficacy. Epidermal Growth factor receptor (EGFr), Human papillomavirus (HPV) and p53 status were also considered.

Results: As expected, overall survival was significantly worse in elderly patients (p=0.005), but response rate, including complete response rate, was similar between the two age groups, as were most of the side effects analyzed. However, infections (p=0.011) and in particular pneumonias (p=0.002) were significantly more represented in elderly patients.

Conclusion: Elderly patients treated with chemo-radiation or bio-radiation in our centre had a higher risk of infection and in particular, pneumonia. These data suggest a more careful follow-up, but age alone does not justify their exclusion from treatment.

Publication types

  • Comparative Study

MeSH terms

  • Age Factors
  • Aged
  • Carcinoma, Squamous Cell / therapy*
  • Combined Modality Therapy / adverse effects*
  • ErbB Receptors / metabolism
  • Female
  • Genes, p53
  • Head and Neck Neoplasms / therapy*
  • Human papillomavirus 16 / isolation & purification
  • Humans
  • Male
  • Middle Aged
  • Retrospective Studies
  • Risk Factors
  • Survival Analysis
  • Survival Rate
  • Treatment Outcome

Substances

  • ErbB Receptors